Transposable elements shape olaparib response according to BRCA1 status in triple-negative breast cancer
Daniela Moreira Mombach, Carlos Mendez‐Dorantes, Rafael L. V. Mercuri…·Pedro A. F. Galante
This paper shows that olaparib treatment increases transposable element activity in BRCA1-deficient triple-negative breast cancer cells, leading to genomic instability and immune responses.